HER2-Positive Metastatic Breast Cancer with Professor Giuseppe Curigliano

Professor Giuseppe Curigliano from the European Institute of Oncology in Milan, Italy discusses recent therapeutic advances in HER2-positive metastatic breast cancer.

CME information and select publications here.